Drug Type Small molecule drug |
Synonyms TL 117, TL-117 |
Target |
Mechanism Phosphatidylinositol 3-kinase family inhibitors |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Recurrent Squamous Cell Carcinoma of the Head and Neck | Phase 2 | - | 01 Apr 2021 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | 01 Apr 2021 | |
Squamous cell carcinoma of head and neck metastatic | Phase 2 | - | 01 Apr 2021 | |
Head and Neck Neoplasms | Preclinical | CN | 02 Apr 2021 |